OTCMKTS:AGTX

Agentix (AGTX) Stock Price, News & Analysis

$0.03
0.00 (0.00%)
(As of 04/24/2024 ET)
Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.05
52-Week Range
$0.03
$0.13
Volume
N/A
Average Volume
20,375 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Agentix

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California.

AGTX Stock Price History

AGTX Stock News Headlines

AGTX - Agentix Corp.
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
See More Headlines
Receive AGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agentix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:AGTX
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Salman Hoda (Age 43)
    CEO, Senior VP Portfolio & Business Development, Secretary, Treasurer and Director
  • Martin Schroeder
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Mr. David Fiene
    Controller

AGTX Stock Analysis - Frequently Asked Questions

How have AGTX shares performed in 2024?

Agentix's stock was trading at $0.0310 at the beginning of the year. Since then, AGTX stock has increased by 3.9% and is now trading at $0.0322.
View the best growth stocks for 2024 here
.

How do I buy shares of Agentix?

Shares of AGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AGTX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners